This is the authors' abstract. We don't add key points for this paper.
Background: We aimed to evaluate the outcomes and toxicity profile in patients with well differentiated thyroid carcinoma (WDTC) treated with intensity modulated radiation therapy (IMRT). Materials and methods:Between June 2007 and July 2011, 18 patients with WDTC received postoperative IMRT with mean radiation dose 66Gy (60-66) delivered with 7 dynamic beams.Median age was 50.5 years (23-66); of whom 10 were males (55.6%) and 8 were females (44.4%).Predominant histology was papillary in 17 patients (94.4%) and predominant T stage was T4 in 15 patients (83.3%).RAI therapy was given to all patients.Results: Median follow up was 53 months (6-55).At 48 months, the Kaplan-Meier estimates of locoregional control, distant control and overall survival were 88.9%, 83.2% and 89.4% respectively.Incomplete surgery, presence of lymphovascular invasion (LVI), and number of >4 positive lymph nodes were found as poor prognostic factors (0.0001).Acute grade 3 Mucositis was experienced in one patient (5.5%) and grade 3 skin toxicity was seen in 1 patient (5.5%).Late toxicities were few and of grade 2.Conclusion: Postoperative IMRT offers excellent locoregional and distant control rates and overall survival with minimal toxicity profile in the treatment of WDTC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
AlAsiri et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: